EconomyMarkets

U.S. to charge Teva in generic drugs price-fixing probe: source By Reuters

© Reuters. FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference in Tel Aviv

(Reuters) – The U.S. Justice Department is preparing to charge Teva Pharmaceutical (NYSE:) Industries Ltd (TA:) with conspiring with competitors to raise prices for generic drugs, according to a person familiar with the matter.

The decision follows Teva’s refusal to agree to a settlement that would have required paying a criminal penalty and admitting wrongdoing, the person https:// said.

Bloomberg Law was first to report the expected lawsuit.

Teva earlier declined to comment on the Bloomberg Law report.

The Justice Department has been investigating allegations the company colluded with other drugmakers to push up the prices of widely used pharmaceuticals, including a high cholesterol drug. Lawyers for Teva had met with Justice Department officials in the spring to discuss a potential settlement, but Teva walked away from the talks in April, the New York Times reported in May.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Source link

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close